Targeting the Roots of Recurrence: New Strategies for Eliminating Therapy-Resistant Breast Cancer Stem Cells
Cancer stem cells (CSCs) are functionally defined in our laboratories by their impressive tumor-generating and self-renewal capacity; clinically, CSCs are of interest because of their enhanced capacity to evade conventional therapies [...]
Main Authors: | Margaret L. Dahn, Paola Marcato |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/1/54 |
Similar Items
-
The Prostaglandin E2 Pathway and Breast Cancer Stem Cells: Evidence of Increased Signaling and Potential Targeting
by: Olivia L. Walker, et al.
Published: (2022-01-01) -
Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum
by: Margaret L. Thomas, et al.
Published: (2018-04-01) -
Advance in Targeted Cancer Therapy and Mechanisms of Resistance
by: Patrick Ming-Kuen Tang, et al.
Published: (2023-11-01) -
Mechanisms of Anticancer Therapy Resistance: The Role of Cancer Stem Cells
by: Julhash U. Kazi
Published: (2020-11-01) -
Special Issue: Resistance to Targeted Therapies in Human Cancer
by: Tae-Won Lee, et al.
Published: (2023-01-01)